← The Wire
XFORNasdaq
X4 Pharmaceuticals, Inc
Biological Products, (No Diagnostic Substances) · DE · CIK 1501697
Develops and commercializes novel therapeutics for rare hematology diseases, including mavorixafor for WHIM syndrome and chronic neutropenia
red 8-K · 90d
$377M
Market cap
$4.23
Last close
+5.2%
1D
+2.7%
5D
592K
Volume
Price · last 39 sessions+0.5%
May 4L $3.64 · H $4.50Jun 29
249
Total filings
May 13, 2026
Last filing
12/31
Fiscal year end
424B5424B5Oct 24, 2025424B5424B5Oct 23, 2025424B5424B5Jun 23, 2025424B5424B5Dec 9, 2022424B5424B5Dec 7, 2022424B5424B5Mar 22, 2022424B5424B5Jan 14, 2022424B5424B5Oct 16, 2020424B5424B5Nov 27, 2019424B5424B5Nov 25, 2019424B5424B5Apr 15, 2019424B5424B5Apr 12, 2019
Insider Activity
In the 90 days to Oct 23, 2025: 1 insider bought $250K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 | Craig Adam RExecutive Chairman | Buy | 86,206 | $2.90 | $250K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance